https://stockwhiz.ai/news/mineralys-therapeutics-presents-new-late-breaking-data-from-transform--a24d03a7Stockwhizen2026-11-08T21:35:00.150ZMineralys Therapeutics Presents New Late-Breaking Data from Transform-HTN Open-Label Extension Trial of Lorundrostat in Hypertension at AHA Scientific Sessions 2026https://stockwhiz.ai/news/vir-biotechnology-announces-primary-endpoint-met-in-pivotal-phase-3-ec-b23881bfStockwhizen2026-11-08T21:15:00.100ZVir Biotechnology Announces Primary Endpoint Met in Pivotal Phase 3 ECLIPSE 1 Trial for Elebsiran and Tobevibart in Chronic Hepatitis Deltahttps://stockwhiz.ai/news/radnet-reports-third-quarter-financial-results-with-record-quarterly-r-3db41230Stockwhizen2026-11-08T21:01:00.383ZRadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Rangeshttps://stockwhiz.ai/news/cideb-sirna-normalizes-liver-fat-and-improves-liver-injury-markers-in--c8efc0e8Stockwhizen2026-11-08T21:00:00.137ZCIDEB siRNA Normalizes Liver Fat and Improves Liver Injury Markers in MASLD Patients, as Highlighted at AASLDhttps://stockwhiz.ai/news/avita-medical-to-host-investor-webinar-briefing-c26c8410Stockwhizen2026-11-08T20:30:00.103ZAVITA Medical to Host Investor Webinar Briefinghttps://stockwhiz.ai/news/statement-from-nvidia-board-of-directors-87d59fbbStockwhizen2026-11-08T20:00:00.108ZStatement from NVIDIA Board of Directorshttps://stockwhiz.ai/news/allergan-aesthetics-reports-improved-satisfaction-with-facial-appearan-de17a405Stockwhizen2026-11-08T17:45:00.032ZAllergan Aesthetics Reports Improved Satisfaction With Facial Appearance Following Aesthetic Treatment in Two Studies of Patients on GLP-1 Medicationshttps://stockwhiz.ai/news/johnson-johnson-reports-73-psa-response-rate-with-investigational-pasr-d79d425aStockwhizen2026-11-08T16:01:20.244ZJohnson & Johnson reports 73% PSA response rate with investigational pasritamig-based immunotherapy combination in advanced prostate cancerhttps://stockwhiz.ai/news/velinotamig-a-bcmaxcd3-t-cell-engager-achieves-complete-renal-response-353a3d2dStockwhizen2026-11-08T15:30:00.131ZVelinotamig, a BCMAxCD3 T Cell Engager, Achieves Complete Renal Responses and Significantly Reduces Disease Activity in Systemic Lupus Erythematosus in Data Presented at ACR Convergence 2026https://stockwhiz.ai/news/crispr-therapeutics-provides-update-on-zugocabtagene-geleucel-zugo-cel-24b2f4fdStockwhizen2026-11-08T15:30:00.094ZCRISPR Therapeutics Provides Update on Zugocabtagene Geleucel (Zugo-cel) in Refractory Rheumatologic Autoimmune Diseaseshttps://stockwhiz.ai/news/cabaletta-bio-presents-new-rese-cel-phase-1-2-clinical-data-at-acr-con-cd0e3a07Stockwhizen2026-11-08T15:00:00.151ZCabaletta Bio Presents New Rese-cel Phase 1/2 Clinical Data at ACR Convergence 2026 Featuring Immunomodulator-Free Durability and Favorable Benefit-Risk Profile Across Autoimmune Diseaseshttps://stockwhiz.ai/news/club-offers-for-travel-enthusiasts-in-germany-86df3ecbStockwhizen2026-11-08T09:56:46.524ZClub Offers for Travel Enthusiasts in Germanyhttps://stockwhiz.ai/news/club-offers-for-travel-enthusiasts-in-canada-e32f5421Stockwhizen2026-11-08T08:14:42.962ZClub Offers for Travel Enthusiasts in Canadahttps://stockwhiz.ai/news/club-offers-for-travel-enthusiasts-in-the-u-s-15d7065bStockwhizen2026-11-08T05:00:00.222ZClub Offers for Travel Enthusiasts in the U.S.https://stockwhiz.ai/news/north-georgia-flooding-u-haul-offers-30-days-free-storage-at-14-stores-6e9124bbStockwhizen2026-11-08T00:28:00.091ZNorth Georgia Flooding: U-Haul Offers 30 Days Free Storage at 14 Storeshttps://stockwhiz.ai/news/club-offers-for-travel-enthusiasts-in-the-uk-4bd2d030Stockwhizen2026-11-08T00:01:00.050ZClub Offers for Travel Enthusiasts in the UKhttps://stockwhiz.ai/news/voyager-awarded-nasa-clps-2-contract-c8d87dd7Stockwhizen2026-11-07T23:00:00.081ZVoyager Awarded NASA CLPS 2 Contracthttps://stockwhiz.ai/news/firefly-aerospace-selected-as-a-vendor-for-nasa-s-10-billion-clps-2-in-d1cf915dStockwhizen2026-11-07T22:55:12.099ZFirefly Aerospace Selected as a Vendor for NASA’s $10 Billion CLPS 2 Initiativehttps://stockwhiz.ai/news/arrowhead-pharmaceuticals-presents-plozasiran-data-highlighting-sustai-490ccf06Stockwhizen2026-11-07T21:15:00.093ZArrowhead Pharmaceuticals Presents Plozasiran Data Highlighting Sustained Triglyceride Reductions and Reduced Acute Pancreatitis Rateshttps://stockwhiz.ai/news/four-course-records-and-28-olympic-trials-qualifiers-highlight-histori-bd132cc6Stockwhizen2026-11-07T21:07:56.350ZFour Course Records and 28 Olympic Trials Qualifiers Highlight Historic 2026 CNO Financial Indianapolis Monumental Marathonhttps://stockwhiz.ai/news/diginex-announces-extension-of-long-stop-date-for-proposed-acquisition-74453c27Stockwhizen2026-11-07T19:07:00.105ZDiginex Announces Extension of Long Stop Date for Proposed Acquisition of Resulticks and Convenes Extraordinary General Meetinghttps://stockwhiz.ai/news/fusion-power-global-capital-branded-streaming-and-neurology-breakthrou-269fcbecStockwhizen2026-11-07T17:06:20.566ZFusion Power, Global Capital, Branded Streaming and Neurology Breakthroughs: New to The Street Show #779 Premieres Tonight on Bloomberg Televisionhttps://stockwhiz.ai/analyst-ratings/iren-limited-ccorf-buy-pt-79-b5f8b10eStockwhizen2026-11-07T15:58:50.810ZCCORF maintains Buy on IREN Limited, maintains PT at $79https://stockwhiz.ai/news/qumulusai-to-report-third-quarter-2026-financial-results-on-nov-10-202-ad767b2aStockwhizen2026-11-07T15:50:00.081ZQumulusAI to Report Third Quarter 2026 Financial Results on Nov. 10, 2026https://stockwhiz.ai/news/johnson-johnson-announces-icotyde-icotrokinra-delivers-significant-imp-bf8100e3Stockwhizen2026-11-07T15:03:00.228ZJohnson & Johnson announces ICOTYDE® (icotrokinra) delivers significant improvement in psoriatic arthritis disease activity among biologic-naive patients with once-daily targeted oral peptidehttps://stockwhiz.ai/news/johnson-johnson-announces-new-phase-2-nipocalimab-study-data-in-sj-gre-f5839c5aStockwhizen2026-11-07T15:03:00.023ZJohnson & Johnson announces new Phase 2 nipocalimab study data in Sjögren's disease that reveal insights on importance of symptom improvements most valued by patientshttps://stockwhiz.ai/news/new-real-world-evidence-presented-by-organon-at-the-american-college-o-47bbc271Stockwhizen2026-11-07T15:00:00.118ZNew Real-World Evidence Presented by Organon at the American College of Rheumatology (ACR) Annual Meeting Evaluated a Large-Scale Switch to HADLIMA® (adalimumab-bwwd) Across United States Veterans Affairs Healthcare Systemhttps://stockwhiz.ai/news/agoda-names-five-quieter-corners-of-asia-to-catch-the-snow-this-season-df121cb5Stockwhizen2026-11-07T03:04:36.958ZAgoda names five quieter corners of Asia to catch the snow this seasonhttps://stockwhiz.ai/news/diversified-royalty-corp-announces-third-quarter-2026-results-7a0662d2Stockwhizen2026-11-07T00:49:33.245ZDiversified Royalty Corp. Announces Third Quarter 2026 Resultshttps://stockwhiz.ai/news/lifemd-reschedules-third-quarter-2026-earnings-release-and-conference--d121f59bStockwhizen2026-11-07T00:25:00.095ZLifeMD Reschedules Third Quarter 2026 Earnings Release and Conference Call to November 12, 2026https://stockwhiz.ai/news/spaccircle-acquisition-corp-announces-the-separate-trading-of-its-clas-d3d705d2Stockwhizen2026-11-07T00:23:37.085ZSPACCircle Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares, Warrants and Rights, Commencing November 10, 2026https://stockwhiz.ai/news/datavault-ai-founder-nathaniel-bradley-sues-board-fa8d24eaStockwhizen2026-11-07T00:04:26.391ZDatavault AI Founder Nathaniel Bradley Sues Boardhttps://stockwhiz.ai/news/james-hardie-industries-set-to-join-s-p-midcap-400-f5468bfdStockwhizen2026-11-06T23:10:19.520ZJames Hardie Industries Set to Join S&P MidCap 400https://stockwhiz.ai/news/biofrontera-inc-to-report-third-quarter-2026-financial-results-on-nove-e9dc8f02Stockwhizen2026-11-06T23:08:00.111ZBiofrontera Inc. to Report Third Quarter 2026 Financial Results on November 13, 2026https://stockwhiz.ai/news/medipharm-labs-sets-date-to-report-third-quarter-2026-financial-result-5f9e5b2fStockwhizen2026-11-06T23:00:00.092ZMediPharm Labs Sets Date to Report Third Quarter 2026 Financial Resultshttps://stockwhiz.ai/news/angiodynamics-announces-inducement-grants-under-nasdaq-listing-rule-56-ebf88f59Stockwhizen2026-11-06T23:00:00.080ZAngioDynamics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)https://stockwhiz.ai/news/bioaffinity-technologies-reports-third-quarter-2026-results-and-contin-d2ef7272Stockwhizen2026-11-06T22:40:00.063ZbioAffinity Technologies Reports Third Quarter 2026 Results and Continued Momentum in CyPath® Lung Commercializationhttps://stockwhiz.ai/news/ten-holdings-reports-third-quarter-2026-financial-results-e2100ae5Stockwhizen2026-11-06T22:30:00.816ZTEN Holdings Reports Third Quarter 2026 Financial Resultshttps://stockwhiz.ai/news/univest-securities-llc-announces-closing-of-1-2-million-registered-dir-8fd816e1Stockwhizen2026-11-06T22:30:00.136ZUnivest Securities, LLC Announces Closing of $1.2 Million Registered Direct Offering for its Client NetClass Technology Inc (NASDAQ: NTCL)https://stockwhiz.ai/news/chicago-rivet-machine-co-announces-third-quarter-results-of-operations-b0fb75cbStockwhizen2026-11-06T22:19:50.108ZChicago Rivet & Machine Co. Announces Third Quarter Results of Operationshttps://stockwhiz.ai/news/constellation-software-inc-announces-results-for-the-third-quarter-end-ab3b8197Stockwhizen2026-11-06T22:08:19.659ZConstellation Software Inc. Announces Results for the Third Quarter Ended September 30, 2026 and Declares Quarterly Dividendhttps://stockwhiz.ai/news/avalon-holdings-corporation-announces-third-quarter-results-886252fcStockwhizen2026-11-06T22:05:00.252ZAVALON HOLDINGS CORPORATION ANNOUNCES THIRD QUARTER RESULTShttps://stockwhiz.ai/news/cognizant-completes-acquisition-of-wizeline-325896d3Stockwhizen2026-11-06T22:00:00.255ZCognizant Completes Acquisition of Wizelinehttps://stockwhiz.ai/news/parker-scheduled-to-present-at-robert-w-baird-global-industrial-confer-23ffbf55Stockwhizen2026-11-06T22:00:00.182ZParker Scheduled to Present at Robert W. Baird Global Industrial Conference on November 10 at 10:50 a.m. Central Time (11:50 a.m. Eastern Time)https://stockwhiz.ai/news/pyrogenesis-schedules-2026-third-quarter-financial-results-and-busines-9eb44111Stockwhizen2026-11-06T22:00:00.127ZPyroGenesis Schedules 2026 Third Quarter Financial Results and Business Update Conference Callhttps://stockwhiz.ai/news/mueller-water-products-to-participate-in-the-baird-2026-global-industr-bf05612aStockwhizen2026-11-06T21:48:26.083ZMueller Water Products to Participate in the Baird 2026 Global Industrial Conferencehttps://stockwhiz.ai/news/zillow-group-to-present-at-rbccm-global-technology-internet-media-tele-0ea68e18Stockwhizen2026-11-06T21:48:04.906ZZillow Group to present at RBCCM Global Technology, Internet, Media & Telecommunications Conferencehttps://stockwhiz.ai/news/mynd-ai-announces-change-to-american-depositary-share-ratio-23d10c44Stockwhizen2026-11-06T21:45:00.283ZMynd.ai Announces Change to American Depositary Share Ratiohttps://stockwhiz.ai/news/surrozen-to-present-at-upcoming-healthcare-investor-conference-d3b69490Stockwhizen2026-11-06T21:40:00.099ZSurrozen to Present at Upcoming Healthcare Investor Conference